Abstract
Control of gene expression is important to gene therapy for purposes of both dosing and safety. In vivo regulation of gene expression was demonstrated following co-injection of two separate recombinant adeno-associated virus vectors, one encoding an inducible murine erythropoietin transgene and the other a transcriptional activator, directly into the skeletal muscle of adult immunocompetent mice. Transcription was controlled by systemic administration or withdrawal of tetracycline over an 18 week period, demonstrating that the two vectors were capable of transducing the same cell. Cellular or humoral immune responses against the transactivator protein were not detected.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Naffakh, N. and Danos, O. 1996. Gene transfer for erythropoiesis enhancement. Mol. Med. Today 2: 343–348.
Gossen, M. and Bujard, H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promotors. Proc. Natl. Acad. Sci. USA 89: 5547–5551.
No, D., Yao, T.P. and Evans, R.M. 1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93: 3346–3351.
Rivera, V.M., Clackson, T., Nateson, S., Pollock, R., Amara, J.F., Keenan, T. et al. 1996. A humanized system for pharmacological control of gene expression. Nat. Med. 2: 1028–1032.
Wang, Y., DeMayo, F.J., Tsai, S.Y. and O'Malley, B.W. 1997. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat. Biotech. 15: 239–243.
Rinsch, C., Regulier, E., Deglon, N., Dalle, B., Beuzard, Y. and Aebischer, P. 1997. A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum. Gene Thar. 8: 1881–1889.
Furth, P.A., St Onge, L., Boger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H. and Hennighausen, L. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promotor. Proc. Natl. Acad. Sci. USA 91: 9302–9306.
Kessler, P.D., Podsakoff, G.M., Chen, X., McQuiston, S.A., Colosi, P.C., Matelis, L.A. et al. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93: 14082–14087.
Xiao, X., Li, J. and Samulski, R.J. 1996. Efficient long-term gene transfer into muscle of immunocompetent mice by an adeno-associated virus vector. J. Virol. 70: 8098–8108.
Fisher, K.J., Jooss, K., Alston, J., Yang, Y., Haecker, S.E., High, K. et al. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3: 306–312.
Murphy, J.E., Zhou, S., Giese, K., Williams, L.T., Escobedo, J.A. and Dwarki, V.J. 1997. Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc. Natl. Acad. Sci. USA 94: 13921–13926.
Snyder, R.O., Spratt, S.K., Lagarde, C., Bohl, D., Kaspar, B.K., Sloan, B.S. et al. 1997. Efficient and stable AAV-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8: 1891–1900.
Clark, K.R., Sferra, T.J. and Johnson, P.R. 1997. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8: 659–669.
Dai, Y., Schwarz, E.M., Gu, D., Zhang, W.-W., Sarvetnick, N. and Verma, I. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92: 1401–1405.
Herzog, R.W., Hagstron, J.N., Kung, S.-H., Tai, S.J., Wilson, J.M., Fisher, K.J. and High, K.A. 1997. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94: 5804–5809.
Hall, Z. and Ralston, E. 1989. Nuclear domains in muscle cells. Cell 59: 771–772.
Snyder, R.O., Miao, C.H., Patijn, G.A., Spratt, S.K., Danos, O., Gown, A.M. et al. 1997. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16: 270–276.
Flannery, J.G., Zolotukhin, S., Vaquero, M.I., LaVail, M.M., Muzyczka, N. and Hauswirth, W.W. 1997. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94: 6916–6921.
Dhawan, J., Rando, T.A., Elson, S.L., Bujard, H. and Blau, H.M. 1995. Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle. Somat. Cell. Mol. Genet. 21: 233–240.
Bohl, D., Naffakh, N. and Heard, J.M. 1997. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat. Med. 3: 299–305.
Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lubbert, H., and Bujard, H. 1996. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93: 10933–10938.
McLaughlin, S.K., Collis, P., Hermonat, P.L. and Muzyczka, N. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62: 1963–1973.
Miao, C.H., Snyder, R.O., Schowalter, D.B., Patijn, G.A., Donahue, B.A., Winther, B. and Kay, M.A. 1998. Kinetics of rAAV Integration in the Liver. Nat. Genet. 19: 13–15.
Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Feigner, P.L., Dwarki, V.J. et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749.
Manning, W.C., Paliard, X., Zhou, S., Bland, M.P., Lee, A.Y., Hong, K. et al. 1997. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J. Virol. 71: 7960–7962.
Mandel, R.J., Rendahl, K.G., Spratt, S.K., Snyder, R.O.L.K. and Leff, S.E. 1998. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-Cyclohydrolase I in a rat model of Parkinson's disease. J. Neurosci. 18: 4271–4284.
Goodman, S., Xiao, X., Donahue, R., Moulton, A., Miller, J., Walsh, C., Young, N.S., Samulski, R.J. and Nienhuis, A.W. 1994. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84: 1492–1500.
McCown, T.J., Xiao, X., Li, J., Breese, G.R. and Samulski, R.J. 1996. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713: 99–107.
Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y. and Phipps, M.L. 1997. Construction of Adenovirus Vectors through Cre-lox Recombination. J. Virol. 71: 1842–1849.
Neering, S.J., Hardy, S.F., Minamoto, D., Spratt, S., and Jordan, C.T. 1996. Transduction of Primitive Human Hematopoietic Cells with Recombinant Adenovirus Vectors. Blood 88: 1147–1155.
Kirk, R.E. 1968. Experimental design: procedures lor the behavioral sciences. Brooks/Cole, Belmont, CA.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rendahl, K., Leff, S., Otten, G. et al. Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 16, 757–761 (1998). https://doi.org/10.1038/nbt0898-757
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0898-757
This article is cited by
-
Cardiac gene therapy: are we there yet?
Gene Therapy (2016)
-
MAR-mediated integration of plasmid vectors for in vivo gene transfer and regulation
BMC Molecular Biology (2013)
-
Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors
Gene Therapy (2010)
-
rAAV-mediated overexpression of FGF-2 promotes cell proliferation, survival, and α-SMA expression in human meniscal lesions
Gene Therapy (2009)
-
AAV vectors for RNA-based modulation of gene expression
Gene Therapy (2008)